Regis Technologies is proud to announce the addition of Ronald L. Mueller, Ph.D. to spearhead our newest offering of Solid State Chemistry (SSC).
Dr. Mueller has more than 25 years in the pharmaceutical industry and over 20 years of preformulation and solid state chemistry experience. After earning his B.Sc. in Chemistry, he studied chemistry at the Karlsruhe Institute of Technology in Germany as a Fulbright Student Scholar and Quadrille-Mobay Fellow. Ron received his Ph.D. in 1990 from the University of Nebraska–Lincoln in Organic Chemistry.
Ron has led Solid State Chemistry teams to contribute to CMC Regulatory modules for several medications (NDAs/MMAs), Drug Master Files, and ANDAs. His industry background includes Sanofi-Winthrop, Bristol-Myers Squibb, GlaxoSmithKline, West Pharmaceutical Services and Johnson-Matthey. He has served in professional affiliations as a volunteer in United States Pharmacopeia, Parenteral Drug Association, Product Quality Research Institute, and as the Chair for Industrial Microscopy at Eastern Analytical Symposium. He is the co-author on many publications and a co-inventor on several patents and/or patent applications.
Ron joined Regis as Director of Solid State Chemistry in March 2019. The SSC service will provide salt, cocrystal, and polymorph screening and selection activities to provide suitable crystallization processes during all development phases for Regis’ Custom Pharma clients. A dedicated laboratory is now underway and will feature state-of-the-art equipment run by Ron and a team of experienced solid state chemists. Learn more about their capabilities here.
Ron and his wife, Amy, live in Northbrook and have two grown sons living in Arlington, VA and Charleston, SC. Ron and Amy are avid hikers and casual kayakers. They enjoy strolling through groomed gardens and parks, and Ron enjoys Class III-V whitewater rafting.